Results 201 to 210 of about 644,115 (313)

Inhibitors of blood coagulation factors Xa and IIa synergize to reduce thrombus weight and thrombin generation in vivo and in vitro

, 2006
Weston R. Gould, Thomas B. McClanahan, Kathleen M. Welch, Sangita M. Baxi, Kamlai Saiya-Cork, L. Chi, Theodore R. Johnson, Robert J. Leadley   +7 more
openalex   +1 more source

Disturbances of selected plasma proteins in Hyperdynamic Septic Shock [PDF]

, 1982
A Ledgerwood, AO Aasen, AO Aasen, CB Laurell, D Collen, DL Heene, DM Rangel, EA Friedmann, EF Gersmeyer, FW Putnam, H Fritz, H Graeff, H Schiessler, H. Fritz, HG Lasch, J Johnson, J. Witte, JW Alexander, K Havemann, K Hochstrasser, K Messmer, K Ohlsson, K. Hochstrasser, M Jochum, M Jochum, M. Jochum, MS Losowsky, N Freudenberg, P Skansberg, PJ Hamilton, PM Starkey, R Dielt, R Egbring, R Hafter, R. Scherer, RG Lerner, W Schramm, W Schramm, W. Schramm   +38 more
core   +1 more source

A computational modeling and molecular dynamics study of the Michaelis complex of human protein Z-dependent protease inhibitor (ZPI) and factor Xa (FXa)

, 2009
V. Chandrasekaran, Chang Jun Lee, Ping Lin, Robert E. Duke, Lee G. Pedersen   +4 more
openalex   +4 more sources

Factor Xa inhibitors: critical considerations for clinical development and testing. [PDF]

J Thromb Thrombolysis, 2021
Becker RC.
europepmc   +1 more source

1P048 Flexible docking multicanonical molecular dynamics simulations between factor Xa and its inhibitors(1. Protein structure and dynamics (I),Poster Session,Abstract,Meeting Program of EABS & BSJ 2006)

, 2006
Narutoshi Kamiya, Yasushige Yonezawa, Haruki Nakamura   +2 more
openalex   +2 more sources

Lufaxin, a Novel Factor Xa Inhibitor From the Salivary Gland of the Sand Fly Lutzomyia longipalpis Blocks Protease-Activated Receptor 2 Activation and Inhibits Inflammation and Thrombosis In Vivo [PDF]

, 2012
Nicolas Collin, Teresa C. F. Assumpção, Daniella M. Mizurini, Dana C. Gilmore, Angélica Dutra-Oliveira, Michail Kotsyfakis, Anderson Sá‐Nunes, Clarissa Teixeira, José M. C. Ribeiro, Robson Q. Monteiro, Jesús G. Valenzuela, Ivo M.B. Francischetti   +11 more
openalex   +1 more source

Incidence and Predictors of Clinical Outcomes in Real-Life Patients With Atrial Fibrillation Treated With Oral Factor Xa Inhibitors: The Follow-Up Results of the ANATOLIA-AF Study. [PDF]

Clin Cardiol
Kocabaş U, Ergin I, Sönmez SC, Yavuz V, Murat S, Özdemir IH, Genç Ö, Tüner H, Meriç BK, Aslan O, Dal A, Taşkın U, Şen T, İbişoğlu E, Erdoğan A, Özgeyik M, Demir M, Urgun ÖD, Doğduş M, Çakal S, Çayırlı S, Güler A, Karabulut D, Dalgıç O, Murat B, Karabulut U, Öztekin GMY, Biter Hİ, Sinan ÜY, Barış VÖ, Kaplan M, Altın C, Kıvrak T.   +32 more
europepmc   +1 more source

A Novel Factor Xa-Inhibiting Peptide from Centipedes Venom [PDF]

, 2013
Yi Kong, Shaoqing Yu, Hao Chen, Xin Ming, Jin-Bin Wang, Zhi-Yu Li, Ji‐Fu Wei   +6 more
openalex   +1 more source

Venous thromboembolism treatment failure during use of factor Xa inhibitors-association with thoracic outlet syndrome and development of chronic thromboembolic pulmonary hypertension. [PDF]

Ann Med
Kaksonen M, Simonen P, Lassila R, Pentikäinen M.   +3 more
europepmc   +1 more source

Effect on Plasma Protein S Activity in Patients Receiving the Factor Xa Inhibitors. [PDF]

J Atheroscler Thromb, 2022
Terakami T, Nagaya S, Hayashi K, Furusho H, Fujino N, Kato T, Asakura H, Morishita E.   +7 more
europepmc   +1 more source